Skip to content

Opening book details…

About this Biochemistry, Genetics and Molecular Biology article

Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients by Cadegiani, F.A. (author);Goren, A. (author);Wambier, C.G. (author);McCoy, J. (author) is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Cadegiani, F.A. (author);Goren, A. (author);Wambier, C.G. (author);McCoy, J. (author)
Publisher
Elsevier BV
Published
2021
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)

More by Cadegiani, F.A. (author);Goren, A. (author);Wambier, C.G. (author);McCoy, J. (author)

Browse all works by Cadegiani, F.A. (author);Goren, A. (author);Wambier, C.G. (author);McCoy, J. (author)